158 related articles for article (PubMed ID: 3861056)
1. Polymorphous exudates and atypical mononuclear cells in the cerebrospinal fluid of patients with Sjögren's syndrome.
de la Monte S; Gupta PK; Hutchins GM
Acta Cytol; 1985; 29(4):634-7. PubMed ID: 3861056
[TBL] [Abstract][Full Text] [Related]
2. Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome.
de la Monte SM; Hutchins GM; Gupta PK
Ann Neurol; 1983 Oct; 14(4):455-61. PubMed ID: 6638957
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
[TBL] [Abstract][Full Text] [Related]
4. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.
Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G
Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741
[TBL] [Abstract][Full Text] [Related]
6. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
[TBL] [Abstract][Full Text] [Related]
7. Primary Sjogren's syndrome with central nervous system involvement.
Alhomoud IA; Bohlega SA; Alkawi MZ; Alsemari AM; Omer SM; Alsenani FM
Saudi Med J; 2009 Aug; 30(8):1067-72. PubMed ID: 19668890
[TBL] [Abstract][Full Text] [Related]
8. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome.
Tuisku IS; Konttinen YT; Konttinen LM; Tervo TM
Exp Eye Res; 2008 Jun; 86(6):879-85. PubMed ID: 18436208
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral manifestation in a case of Sjögren's syndrome (author's transl)].
Maida E; Kristoferitsch W
Wien Klin Wochenschr; 1979 May; 91(10):337-9. PubMed ID: 452603
[TBL] [Abstract][Full Text] [Related]
10. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome: a condition with features of chronic graft-versus-host disease: does duct cell adhesion or permeability play a role in pathogenesis?
Lamey PJ; Lundy FT; Al-Hashimi I
Med Hypotheses; 2004; 62(5):825-9. PubMed ID: 15082115
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Flt3 ligand correlates to tau protein levels in primary Sjögren's syndrome.
Dehlin M; Bjersing J; Erlandsson M; Andreasen N; Zetterberg H; Mannerkorpi K; Bokarewa M
Scand J Rheumatol; 2013; 42(5):394-9. PubMed ID: 23837643
[TBL] [Abstract][Full Text] [Related]
13. Atypical neurologic complications in patients with primary Sjögren's syndrome: report of 4 cases.
Michel L; Toulgoat F; Desal H; Laplaud DA; Magot A; Hamidou M; Wiertlewski S
Semin Arthritis Rheum; 2011 Feb; 40(4):338-42. PubMed ID: 20701954
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Gudbjörnsson B; Valtysdóttir S; Björnsson E; Roomans GM; Boman G; Sevéus L; Venge P;
Respir Med; 2001 Nov; 95(11):904-10. PubMed ID: 11716205
[TBL] [Abstract][Full Text] [Related]
15. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome.
Papiris SA; Saetta M; Turato G; La Corte R; Trevisani L; Mapp CE; Maestrelli P; Fabbri LM; Potena A
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):637-41. PubMed ID: 9279251
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Tzioufas AG; Skopouli FN
Ann Med Interne (Paris); 1998 Feb; 149(1):17-24. PubMed ID: 11490512
[TBL] [Abstract][Full Text] [Related]
17. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
Mackay F; Groom JR; Tangye SG
Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
[TBL] [Abstract][Full Text] [Related]
18. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
Friedman J; Schattner A; Shvidel L; Berrebi A
Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
[TBL] [Abstract][Full Text] [Related]
19. [A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation].
Arai C; Furutani R; Ushiyama M
Rinsho Shinkeigaku; 2002 Jul; 42(7):613-8. PubMed ID: 12661106
[TBL] [Abstract][Full Text] [Related]
20. [Morphology of the minor salivary glands in Sjogren's disease].
Kop'eva TN; Pozharitskaia MM; Makarova OV
Arkh Patol; 1994; 56(3):38-46. PubMed ID: 8092939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
